Bacitracin Zinc And Polymyxin B Sulfates
Prescription品牌名称： polycin
About This Medication
DESCRIPTION: Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP, is a sterile antimicrobial ointment for ophthalmic use. Each gram contains: bacitracin zinc equivalent to 500 bacitracin units, polymyxin B sulfate equivalent to 10,000 polymyxin B units, mineral oil, and white petrolatum. Bacitracin zinc is the zinc salt of bacitracin, a mixture of related cyclic polypeptides (mainly bacitracin A) produced by the growth of an organism of the licheniformis group of Bacillus subtilis var Tracy. It has a potency of not less than 40 bacitracin units per mg. The structural formula for bacitracin A is: Polymyxin B sulfate is the sulfate salt of polymyxin B 1 and B 2 which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae ). It has a potency of not less than 6,000 polymyxin B units per mg, calculated on an anhydrous basis. The structural formulae are: Structural Formula Image 1 Structural Formula Image 2
活性成分
| 成分 | 规格 |
|---|---|
| Bacitracin Zinc | - |
| Polymyxin B Sulfate | - |
适应证与用法
用法用量
Side Effects Overview
警告与注意事项
WARNINGS: NOT FOR INJECTION INTO THE EYE. Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment should never be directly introduced into the anterior chamber of the eye. Ophthalmic ointments may retard corneal wound healing. Topical antibiotics may cause cutaneous sensitization. A precise incidence of hypersensitivity reactions (primarily skin rash) due to topical antibiotics is not known. The manifestations of sensitization to topical antibiotics are usually itching, reddening, and edema of the conjunctiva and eyelid. A sensitization reaction may manifest simply, as a failure to heal. During long-term use of topical antibiotic products, periodic examination for such signs is advisable, and the patient should be told to discontinue the product if they are observed. Symptoms usually subside quickly on withdrawing the medication. Application of products containing these ingredients should be avoided for the patient thereafter (see PRECAUTIONS: General ).
禁忌证
CONTRAINDICATIONS: Polycin® Ophthalmic Ointment is contraindicated in individuals who have shown hypersensitivity to any of its components.
Frequently Asked Questions
INDICATIONS AND USAGE: Polycin® Ophthalmic Ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. Such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis.
DOSAGE AND ADMINISTRATION: May be applied every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection.
WARNINGS: NOT FOR INJECTION INTO THE EYE. Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment should never be directly introduced into the anterior chamber of the eye. Ophthalmic ointments may retard corneal wound healing. Topical antibiotics may cause cutaneous sensitization. A precise incidence of hypersensitivity reactions (primarily skin rash) due to topical antibiotics is not known. The manifestations of sensitization to topical antibiotics are usually itching, reddening, and edema of the conjunctiva and eyelid. A sensitization reaction may manifest simply, …
CONTRAINDICATIONS: Polycin® Ophthalmic Ointment is contraindicated in individuals who have shown hypersensitivity to any of its components.
Bacitracin Zinc And Polymyxin B Sulfates is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Drops Products
Browse all Drops products →References & Data Sources
- • DailyMed — Bacitracin Zinc And Polymyxin B Sulfates drug label (National Library of Medicine)
- • openFDA — Bacitracin Zinc And Polymyxin B Sulfates label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 213621 (NLM Normalized Drug Names)
- • NDC Directory — Bacitracin Zinc And Polymyxin B Sulfates (FDA National Drug Code)
医疗免责声明
本页面信息仅供教育参考之用，不得用于替代专业医疗建议、诊断或治疗。
如有任何关于病症或药物的疑问，请务必咨询您的医生或其他具有资质的医疗保健提供者。
数据来源： DailyMed (NLM), openFDA, MFDS